Nationwide Fund Advisors’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-22,952
Closed -$1.15M 666
2017
Q3
$1.15M Sell
22,952
-26,347
-53% -$1.27M ﹤0.01% 1704
2017
Q2
$2.28M Buy
49,299
+10,013
+25% +$368K 0.01% 1370
2017
Q1
$1.39M Buy
39,286
+921
+2% +$21.1K 0.01% 1580
2016
Q4
$480K Sell
38,365
-1,300
-3% -$15.5K ﹤0.01% 2193
2016
Q3
$549K Buy
39,665
+3,801
+11% +$43.1K ﹤0.01% 2136
2016
Q2
$354K Buy
35,864
+18,100
+102% +$300K ﹤0.01% 2328
2016
Q1
$300K Hold
17,764
﹤0.01% 2342
2015
Q4
$395K Buy
17,764
+6,251
+54% +$158K ﹤0.01% 2234
2015
Q3
$272K Buy
11,513
+3,000
+35% +$188K ﹤0.01% 2413
2015
Q2
$696K Buy
8,513
+3,852
+83% +$377K ﹤0.01% 2061
2015
Q1
$432K Buy
4,661
+131
+3% +$8.45K ﹤0.01% 2306
2014
Q4
$183K Buy
4,530
+1,032
+30% +$31.6K ﹤0.01% 2678
2014
Q3
$86K Hold
3,498
﹤0.01% 3026
2014
Q2
$55K Sell
3,498
-137
-4% -$1.98K ﹤0.01% 3094
2014
Q1
$55K Hold
3,635
﹤0.01% 2844
2013
Q4
$50K Buy
3,635
+2,360
+185% +$34.3K ﹤0.01% 3064
2013
Q3
$24K Buy
+1,275
New +$21.4K ﹤0.01% 3085

Other funds holding ESPR